Literature DB >> 11447183

Neisseria meningitidis lipopolysaccharide modulates the specific humoral immune response to neisserial porins but has no effect on porin-induced upregulation of costimulatory ligand B7-2.

N Bhasin1, Y Ho, L M Wetzler.   

Abstract

The role of lipopolysaccharide (LPS) in the specific humoral response to meningococcal porins was investigated by measuring anti-PorA or -PorB antibody levels in mice immunized with wild-type meningococcal strain H44/76 or with its recently described LPS-negative mutant. Two murine strains were used for these immunizations: C3H/HeJ, which is LPS hyporesponsive, or C3H/HeOuJ, which is LPS responsive. A high level of anti-PorB immunoglobulin G (IgG) response was induced in both strains of mice immunized with either organism. The response induced by the wild-type strain was greater in C3H/HeOuJ mice than in C3H/HeJ mice, while the response induced by the LPS-negative mutant was similar in the two murine strains. Additionally, the anti-PorB response was similar in C3H/HeJ mice immunized with either bacterial strain. In general, the anti-PorA IgG response was lower than the anti-PorB response. These findings indicate that the presence of LPS is not essential for the induction of an antineisserial porin humoral response but can augment such a response. To determine whether LPS has any effect on the B-cell-stimulatory effect of neisserial porins (essential for the adjuvant activity of neisserial porins), B cells from both murine strains were incubated with outer membrane complexes (OMCs) prepared from strain H44/76 and its LPS-negative mutant. OMCs from either meningococcal strain were able to increase the surface expression of the costimulatory ligand B7-2 on B cells from either murine strain. Consistent with previously reported findings, LPS does not significantly affect the ability of neisserial porins to induce the costimulatory ligand B7-2.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11447183      PMCID: PMC98597          DOI: 10.1128/IAI.69.8.5031-5036.2001

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  34 in total

Review 1.  Meningococcal molecular mimicry and the search for an ideal vaccine.

Authors:  J M Griffiss; R Yamasaki; M Estabrook; J J Kim
Journal:  Trans R Soc Trop Med Hyg       Date:  1991       Impact factor: 2.184

Review 2.  Vaccines for gonorrhea: where are we on the curve?

Authors:  M S Blake; L M Wetzler
Journal:  Trends Microbiol       Date:  1995-12       Impact factor: 17.079

3.  The role of B/T costimulatory signals in the immunopotentiating activity of neisserial porin.

Authors:  F G Mackinnon; Y Ho; M S Blake; F Michon; A Chandraker; M H Sayegh; L M Wetzler
Journal:  J Infect Dis       Date:  1999-09       Impact factor: 5.226

4.  Human antibody response to a group B serotype 2a meningococcal vaccine determined by immunoblotting.

Authors:  E Wedege; L O Frøholm
Journal:  Infect Immun       Date:  1986-02       Impact factor: 3.441

5.  Immunogenicity of a Haemophilus influenzae polysaccharide-Neisseria meningitidis outer membrane protein complex conjugate vaccine.

Authors:  J J Donnelly; R R Deck; M A Liu
Journal:  J Immunol       Date:  1990-11-01       Impact factor: 5.422

6.  Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene.

Authors:  A Poltorak; X He; I Smirnova; M Y Liu; C Van Huffel; X Du; D Birdwell; E Alejos; M Silva; C Galanos; M Freudenberg; P Ricciardi-Castagnoli; B Layton; B Beutler
Journal:  Science       Date:  1998-12-11       Impact factor: 47.728

7.  Meningococcal disease in The Netherlands, 1958-1990: a steady increase in the incidence since 1982 partially caused by new serotypes and subtypes of Neisseria meningitidis.

Authors:  R J Scholten; H A Bijlmer; J T Poolman; B Kuipers; D A Caugant; L Van Alphen; J Dankert; H A Valkenburg
Journal:  Clin Infect Dis       Date:  1993-02       Impact factor: 9.079

8.  Humoral immune response to class 1 outer membrane protein during the course of meningococcal disease.

Authors:  H K Guttormsen; L M Wetzler; C O Solberg
Journal:  Infect Immun       Date:  1994-04       Impact factor: 3.441

9.  Peptides bound to proteosomes via hydrophobic feet become highly immunogenic without adjuvants.

Authors:  G H Lowell; L F Smith; R C Seid; W D Zollinger
Journal:  J Exp Med       Date:  1988-02-01       Impact factor: 14.307

10.  Neisserial porins induce B lymphocytes to express costimulatory B7-2 molecules and to proliferate.

Authors:  L M Wetzler; Y Ho; H Reiser; L W Wetzler
Journal:  J Exp Med       Date:  1996-03-01       Impact factor: 14.307

View more
  2 in total

1.  Induction of cytokine mRNA expression in U937 cells by Salmonella typhimurium porins is regulated by different phosphorylation pathways.

Authors:  Marilena Galdiero; Annalisa Tortora; Nicola Damiano; Mariateresa Vitiello; Anna Longanella; Emilia Galdiero
Journal:  Med Microbiol Immunol       Date:  2005-01       Impact factor: 3.402

2.  Role of protein tyrosine kinase and Erk1/2 activities in the Toll-like receptor 2-induced cellular activation of murine B cells by neisserial porin.

Authors:  Heather MacLeod; Navneet Bhasin; Lee M Wetzler
Journal:  Clin Vaccine Immunol       Date:  2008-02-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.